Skip to main content
drug protocol number
VX21-CTX001-161
drug sponsor
Vertex Pharmaceuticals
drug study
Autologous CRISPR Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (CTX001)
drug trial site
King Faisal Specialist Hospital and Research Center (Riyadh)
drug status
Ongoing
drug phase